Enfortumab vedotin, an anti-Nectin-4 ADC demonstrates bystander cell killing and immunogenic cell death anti-tumor activity mechanisms of action in urothelial cancers
- Resource Type
- Journal
- Source
CANCER RESEARCH ; AUG 2020, 80 16, 2p. Supplement: S- Subject
- Language
- English
- ISSN
- 15387445